Her 2 and topoisomerase (TOPO)IIα as predictive markers for node-positive (N+) breast cancer (BC) patients (PTS) randomised to adjuvant CMF or epirubicin (E)cyclophosphamide (C)

被引：1

作者：

Di Leo, A

Larsimont, D

Beauduin, M

Vindevoghel, A

Michel, J

Dolci, S

Bartolomeus, S

Lobelle, JP

Paesmans, M

Piccart, M

机构：

[1] Inst Jules Bordet, B-1000 Brussels, Belgium

[2] Belgian Cooperat Ctr, Brussels, Belgium

[3] Pharmacia & Upjohn Inc, Puurs, Belgium

来源：

关键词：

D O I：

10.1016/S0959-8049(99)81230-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

802

引用

页码：S205 / S206

页数：2